Kestra Private Wealth Services’s Definium Therapeutics DFTX Stock Holding History

Kestra Private Wealth Services’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$956K	Buy	50,588 +448	+0.9%	+$7.6K	0.01%	862
2025 Q4	$671K	Hold	50,140	–	–	0.01%	1007
2025 Q3	$591K	Hold	50,140	–	–	0.01%	1027
2025 Q2	$325K	Sell	50,140 -66	-0.1%	-$434	﹤0.01%	1237
2025 Q1	$294K	Sell	50,206 -1,000	-2%	-$7.16K	﹤0.01%	1214
2024 Q4	$356K	Sell	51,206 -133	-0.3%	-$915	0.01%	1071
2024 Q3	$292K	Hold	51,339	–	–	0.01%	1091
2024 Q2	$370K	Hold	51,339	–	–	0.01%	958
2024 Q1	$483K	Hold	51,339	–	–	0.01%	811
2023 Q4	$188K	Hold	51,339	–	–	﹤0.01%	1110
2023 Q3	$161K	Hold	51,339	–	–	0.01%	1053
2023 Q2	$183K	Hold	51,339	–	–	0.01%	975
2023 Q1	$163K	Sell	51,339 -133	-0.3%	-$442	0.01%	952
2022 Q4	$113K	Buy	51,472 +1,000	+2%	+$2.78K	0.01%	840
2022 Q3	$177K	Buy	+50,472	New	+$485K	0.01%	801

Other funds holding DFTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Kestra Private Wealth Services's DFTX Position: Q1 2026 in Review

Kestra Private Wealth Services increased its Definium Therapeutics (DFTX) stake by 0.89% in Q1 2026, buying an estimated $7.6K and bringing the position to 50,588 shares worth $956K. The position accounts for 0.01% of the portfolio, ranked #862.

Kestra Private Wealth Services first reported a position in DFTX in Q3 2022 and has held it in 15 quarters since. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

Kestra Private Wealth Services held 50,588 shares of Definium Therapeutics worth $956K as of Q1 2026.
Kestra Private Wealth Services bought 448 Definium Therapeutics shares in Q1 2026, an estimated $7.6K.
Definium Therapeutics made up 0.01% of Kestra Private Wealth Services's portfolio in Q1 2026, its #862 holding.
Kestra Private Wealth Services first reported a position in Definium Therapeutics in Q3 2022 and has held it in 15 quarters since.
247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Kestra Private Wealth Services's 13F filing for Q1 2026, filed 20 Apr 2026.